Santalis write down!
![]()
no revenues expected for 7 years (previously 1 year), OTC products no longer guaranteed success, prescription products downgraded from possible to bloody unlikely. Valuation? big fat donut!
Whodathunk.
- Forums
- ASX - By Stock
- QIN
- Ann: Annual Report to shareholders
Ann: Annual Report to shareholders, page-12
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)